Ligand validation:4IXR

LHG: 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE

LHG is a Ligand Of Interest in 4IXR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IXR_LHG_A_412	10%	48%	0.289	0.833	1.05	0.98	2	2	0	0	80%	0.7959
4IXR_LHG_a_414	3%	47%	0.411	0.798	1.07	1	2	2	0	0	80%	0.7959
4IXR_LHG_a_417	2%	46%	0.372	0.701	1.09	1.01	2	2	0	0	76%	0.7551
4IXR_LHG_A_415	0%	45%	0.574	0.623	1.08	1.08	2	2	0	0	76%	0.7551
5V2C_LHG_l_101	98%	46%	0.068	0.987	0.91	1.18	2	3	0	0	100%	1
7RF1_LHG_D_410	91%	47%	0.087	0.974	0.92	1.14	2	5	0	0	100%	1
8IRC_LHG_L_101	91%	48%	0.092	0.978	0.88	1.15	2	4	0	0	100%	1
5B66_LHG_l_102	91%	54%	0.084	0.969	0.78	1	2	2	0	0	100%	1
4IL6_LHG_B_621	91%	52%	0.088	0.973	0.93	0.92	2	2	0	0	100%	1
8F4H_LHG_D_407	90%	50%	0.091	0.974	0.71	1.2	1	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.